Debt & Credit Markets

Panama finalizes its multi-billion dollar bond tender offer, a strategic move to refinance debt amid fiscal pressures and a changing economic landscape.

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

NFL star Shawne Merriman alleges his lender is attempting a hostile takeover of his company, sparking a high-stakes legal battle over corporate control.

The Virginia bank replaced costly floating-rate debt with a fixed-rate offering, signaling strong investor confidence and fortifying its capital base.

The legal tech firm is cleared for trading after a two-month halt, now focusing on debt reduction using proceeds from a major UK asset divestiture.

With a massively oversubscribed bond sale and upgraded credit ratings, Italian API giant FIS solidifies its finances to expand in a booming pharma market.

The tech giant's savvy financial moves are set to save $27M annually, extending maturities and freeing up cash for future innovation and growth.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

Pharming Group projects strong 2026 growth, fueling ambitious clinical programs for rare immunodeficiencies and mitochondrial diseases.

An agri-tech firm's $5M loan for a historic Ohio property reveals a pivot to tokenized real estate, but financial woes and a CEO-linked deal raise questions.